|
1
|
Anversa P and Sonnenblick EH: Ischemic
cardiomyopathy: pathophysiologic mechanisms. Prog Cardiovasc Dis.
33:49–70. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Eltzschig HK and Eckle T: Ischemia and
reperfusion - from mechanism to translation. Nat Med. 17:1391–1401.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Takimoto E and Kass DA: Role of oxidative
stress in cardiac hypertrophy and remodeling. Hypertension.
49:241–248. 2007. View Article : Google Scholar
|
|
4
|
Zhang J, Wei C, Wang H, Tang S, Jia Z,
Wang L, Xu D and Wu Y: Protective effect of qiliqiangxin capsule on
energy metabolism and myocardial mitochondria in pressure overload
heart failure rats. Evid Based Complement Alternat Med.
2013:3782982013.PubMed/NCBI
|
|
5
|
Wan Z, Root-McCaig J, Castellani L, Kemp
BE, Steinberg GR and Wright DC: Evidence for the role of AMPK in
regulating PGC-1alpha expression and mitochondrial proteins in
mouse epididymal adipose tissue. Obesity (Silver Spring).
22:730–738. 2014. View Article : Google Scholar
|
|
6
|
Lai L, Wang M, Martin OJ, Leone TC, Vega
RB, Han X and Kelly DP: A role for peroxisome
proliferator-activated receptor γ coactivator 1 (PGC-1) in the
regulation of cardiac mitochondrial phospholipid biosynthesis. J
Biol Chem. 289:2250–2259. 2014. View Article : Google Scholar :
|
|
7
|
Wu Z, Puigserver P, Andersson U, Zhang C,
Adelmant G, Mootha V, Troy A, Cinti S, Lowell B, Scarpulla RC and
Spiegelman BM: Mechanisms controlling mitochondrial biogenesis and
respiration through the thermogenic coactivator PGC-1. Cell.
98:115–124. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cimino F, Speciale A, Anwar S, Canali R,
Ricciardi E, Virgili F, Trombetta D and Saija A: Anthocyanins
protect human endothelial cells from mild hyperoxia damage through
modulation of Nrf2 pathway. Genes Nutr. 8:391–399. 2013. View Article : Google Scholar :
|
|
9
|
Zhou S, Sun W, Zhang Z and Zheng Y: The
role of Nrf2-mediated pathway in cardiac remodeling and heart
failure. Oxid Med Cell Longev. 2014:2604292014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hybertson BM, Gao B, Bose SK and McCord
JM: Oxidative stress in health and disease: the therapeutic
potential of Nrf2 activation. Mol Aspects Med. 32:234–246. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nie PH, Zhang L, Zhang WH, Rong WF and Zhi
JM: The effects of hydroxysafflor yellow A on blood pressure and
cardiac function. J Ethnopharmacol. 139:746–750. 2012. View Article : Google Scholar
|
|
12
|
Feng ZM, He J, Jiang JS, Chen Z, Yang YN
and Zhang PC: NMR solution structure study of the representative
component hydroxysafflor yellow A and other quinochalcone
C-glycosides from Carthamus tinctorius. J Nat Prod. 76:270–274.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Han SY, Li HX, Ma X, Zhang K, Ma ZZ and Tu
PF: Protective effects of purified safflower extract on myocardial
ischemia in vivo and in vitro. Phytomedicine. 16:694–702. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu SX, Zhang Y, Wang YF, Li XC, Xiang MX,
Bian C and Chen P: Upregulation of heme oxygenase-1 expression by
hydroxysafflor yellow A conferring protection from
anoxia/reoxygenation-induced apoptosis in H9c2 cardiomyocytes. Int
J Cardiol. 160:95–101. 2012. View Article : Google Scholar
|
|
15
|
Park B, Sung B, Yadav VR, Cho SG, Liu M
and Aggarwal BB: Acetyl-11-keto-β-boswellic acid suppresses
invasion of pancreatic cancer cells through the downregulation of
CXCR4 chemokine receptor expression. Int J Cancer. 129:23–33. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang Y, Sun Y, Wang C, Huo X, Liu P, Wang
C, Zhang B, Zhan L, Zhang H, Deng S, et al: Biotransformation of
11-keto-β-boswellic acid by Cunninghamella blakesleana.
Phytochemistry. 96:330–336. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Henkel A, Kather N, Mönch B, Northoff H,
Jauch J and Werz O: Boswellic acids from frankincense inhibit
lipopolysaccharide functionality through direct molecular
interference. Biochem Pharmacol. 83:115–121. 2012. View Article : Google Scholar
|
|
18
|
Ding Y, Chen M, Wang M, Wang M, Zhang T,
Park J, Zhu Y, Guo C, Jia Y, Li Y and Wen A: Neuroprotection by
acetyl-11-keto-β-Boswellic acid, in ischemic brain injury involves
the Nrf2/HO-1 defense pathway. Sci Rep. 4:70022014. View Article : Google Scholar
|
|
19
|
Stanely Mainzen Prince P and Roy AJ:
p-Coumaric acid attenuates apoptosis in isoproterenol-induced
myocardial infarcted rats by inhibiting oxidative stress. Int J
Cardiol. 168:3259–3266. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tian Y, Yang ZF, Li Y, Qiao Y, Yang J, Jia
YY and Wen AD: Pharmacokinetic comparisons of hydroxysafflower
yellow A in normal and blood stasis syndrome rats. J
Ethnopharmacol. 129:1–4. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yadav VR, Prasad S, Sung B, Gelovani JG,
Guha S, Krishnan S and Aggarwal BB: Boswellic acid inhibits growth
and metastasis of human colorectal cancer in orthotopic mouse model
by down-regulating inflammatory, proliferative, invasive and
angiogenic biomarkers. Int J Cancer. 130:2176–2184. 2012.
View Article : Google Scholar
|
|
22
|
Woo AY, Cheng CH and Waye MM: Baicalein
protects rat cardiomyocytes from hypoxia/reoxygenation damage via a
prooxidant mechanism. Cardiovasc Res. 65:244–253. 2005. View Article : Google Scholar
|
|
23
|
Tomaselli GF and Barth AS: Sudden cardio
arrest: oxidative stress irritates the heart. Nat Med. 16:648–649.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cadenas E and Davies KJ: Mitochondrial
free radical generation, oxidative stress, and aging. Free Radic
Biol Med. 29:222–230. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Green DR and Kroemer G: The
pathophysiology of mitochondrial cell death. Science. 305:626–629.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Smith RA, Hartley RC, Cochemé HM and
Murphy MP: Mitochondrial pharmacology. Trends Pharmacol Sci.
33:341–352. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen Q and Lesnefsky EJ: Depletion of
cardiolipin and cytochrome c during ischemia increases hydrogen
peroxide production from the electron transport chain. Free Radic
Biol Med. 40:976–982. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen YR and Zweier JL: Cardiac
mitochondria and reactive oxygen species generation. Circ Res.
114:524–537. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Warner DS, Sheng H and Batinić-Haberle I:
Oxidants, antioxidants and the ischemic brain. J Exp Biol.
207:3221–3231. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Halliwell B and Gutteridge J: Free
Radicals in Biology and Medicine. 1st edition. Oxford University
Press; New York, NY: 2007
|
|
31
|
Hartmann RM, Morgan Martins MI, Tieppo J,
Fillmann HS and Marroni NP: Effect of Boswellia serrata on
antioxidant status in an experimental model of colitis rats induced
by acetic acid. Dig Dis Sci. 57:2038–2044. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li J, Ma X, Yu W, Lou Z, Mu D, Wang Y,
Shen B and Qi S: Reperfusion promotes mitochondrial dysfunction
following focal cerebral ischemia in rats. PLoS One. 7:e464982012.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
St-Pierre J, Drori S, Uldry M, Silvaggi
JM, Rhee J, Jäger S, Handschin C, Zheng K, Lin J, Yang W, et al:
Suppression of reactive oxygen species and neurodegeneration by the
PGC-1 transcriptional coactivators. Cell. 127:397–408. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wei X, Liu H, Sun X, Fu F, Zhang X, Wang
J, An J and Ding H: Hydroxysafflor yellow A protects rat brains
against ischemia-reperfusion injury by antioxidant action. Neurosci
Lett. 386:58–62. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kressler D, Schreiber SN, Knutti D and
Kralli A: The PGC-1-related protein PERC is a selective coactivator
of estrogen receptor alpha. J Biol Chem. 277:13918–13925. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Joshi G and Johnson JA: The Nrf2-ARE
pathway: A valuable therapeutic target for the treatment of
neurodegenerative diseases. Recent Patents CNS Drug Discov.
7:218–229. 2012. View Article : Google Scholar
|
|
37
|
Ma X, Oyamada S, Gao F, Wu T, Robich MP,
Wu H, Wang X, Buchholz B, McCarthy S, Gu Z, et al:
Paclitaxel/sirolimus combination coated drug-eluting stent: In
vitro and in vivo drug release studies. J Pharm Biomed Anal.
54:807–811. 2011. View Article : Google Scholar
|
|
38
|
Gaziano TA, Galea G and Reddy KS: Scaling
up interventions for chronic disease prevention: the evidence.
Lancet. 370:1939–1946. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Robich MP, Chu LM, Oyamada S, Sodha NR and
Sellke FW: Myocardial therapeutic angiogenesis: a review of the
state of development and future obstacles. Expert Rev Cardiovasc
Ther. 9:1469–1479. 2011. View Article : Google Scholar : PubMed/NCBI
|
